Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000189751 | SCV000243399 | pathogenic | not provided | 2012-12-11 | criteria provided, single submitter | clinical testing | p.Leu104Stop (TTG>TAG): c.311 T>A in exon 4 of the TPP1 gene (NM_000391.3)The Leu104Stop nonsense mutation in the TPP1 gene, associated with neuronal ceroid lipofuscinosis (NCL), was cited in a published paper reporting on novel human pathological mutations (Kohan et al., 2008). This mutation is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The variant is found in CHILD-EPI panel(s). |
Ambry Genetics | RCV000210549 | SCV000262853 | pathogenic | Inborn genetic diseases | 2014-04-10 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000984312 | SCV001163323 | pathogenic | Neuronal ceroid lipofuscinosis 2 | criteria provided, single submitter | clinical testing | ||
Invitae | RCV000189751 | SCV001591922 | pathogenic | not provided | 2023-09-23 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu104*) in the TPP1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TPP1 are known to be pathogenic (PMID: 10330339). This variant is present in population databases (rs202189057, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with focal seizures and neuronal ceroid lipofuscinosis (PMID: 19793312, 23266810, 23539563, 26795593). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 207561). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV002492873 | SCV002809851 | pathogenic | Neuronal ceroid lipofuscinosis 2; Autosomal recessive spinocerebellar ataxia 7 | 2021-10-28 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000984312 | SCV001132495 | likely pathogenic | Neuronal ceroid lipofuscinosis 2 | 2015-04-01 | no assertion criteria provided | clinical testing |